Area of research
Hepatology · Epidemiology
Research interest
Research interests include Medicine, Internal medicine, Hepatic encephalopathy, Cirrhosis, Gastroenterology, and Liver transplantation.
Recovery of right ventricular function after intermediate-risk pulmonary embolism: results from the multicentre Pulmonary Embolism International Trial (PEITHO)-2
Disturbed Glucose Metabolism and Left Ventricular Geometry in the General Population
Association between diabetes mellitus and hepatic encephalopathy in patients with cirrhosis
Clinical Frailty Scale for Risk Stratification in Patients with Sars-Cov-2 Infection
Outcome Prediction of Covert Hepatic Encephalopathy in Liver Cirrhosis: Comparison of Four Testing Strategies
Liver injury in patients with severe acute respiratory syndrome coronavirus-2 infection: a systematic review and meta-analysis
Is <i>APOE</i> ε4 associated with cognitive performance in early MS?
Association between medicated obstructive pulmonary disease, depression and subjective health: results from the population-based Gutenberg Health Study
Health-related quality of life in patients with compensated and decompensated liver cirrhosis
Raised serum Interleukin‐6 identifies patients with liver cirrhosis at high risk for overt hepatic encephalopathy
Development and Validation of a Prognostic Score to Predict Covert Hepatic Encephalopathy in Patients With Cirrhosis
Sarcopenia as prognostic factor for survival after orthotopic liver transplantation
Computational issues in fitting joint frailty models for recurrent events with an associated terminal event
Cirrhosis Risk Score of the Donor Organ Predicts Early Fibrosis Progression after Liver Transplantation
Cirrhosis risk score of the donor organ predicts early fibrosis progression after liver transplantation
Prospective evaluation of the impact of covert hepatic encephalopathy on quality of life and sleep in cirrhotic patients
Development and validation of a score to detect paroxysmal atrial fibrillation after stroke
Validation of the simplified Animal Naming Test as primary screening tool for the diagnosis of covert hepatic encephalopathy
Improved Prediction of Survival by a Risk Factor-Integrating Inflammatory Score in Sorafenib-Treated Hepatocellular Carcinoma
Clinical Predictors for Poor Quality of Life in Patients With Covert Hepatic Encephalopathy
Association of smoking but not HLA-DRB1*15:01, <i>APOE</i> or body mass index with brain atrophy in early multiple sclerosis
Personality Traits and Physical Complaints in Patients With Acromegaly: A Cross Sectional Multi-Center Study With Analysis of Influencing Factors